# Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

> **NCT03262389** · PHASE2 · COMPLETED · sponsor: **Michael C Roarke, MD** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Fludeoxyglucose PET CT
- **DRUG:** Sodium Acetate C11 PET CT
- **DRUG:** Fludeoxyglucose PET MRI
- **DRUG:** Sodium Acetate C11 PET MRI

## Key facts

- **NCT ID:** NCT03262389
- **Lead sponsor:** Michael C Roarke, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-19
- **Primary completion:** 2019-11-23
- **Final completion:** 2019-11-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262389, "Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03262389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*